Opaleye Management Inc. - 09 May 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Issuer symbol
TARA
Transactions as of
09 May 2024
Net transactions value
-$566,951
Form type
4
Filing time
10 May 2024, 18:57:46 UTC
Previous filing
25 Apr 2024
Next filing
17 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock, par value $0.001 per share Sale $94,526 -30,600 -1.2% $3.09 2,531,994 09 May 2024 By Opaleye, L.P. F1, F2
transaction TARA Common Stock, par value $0.001 per share Sale $472,424 -151,700 -6% $3.11 2,380,294 10 May 2024 By Opaleye, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.05-$3.15 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F3 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.20 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.